Search A Light In The Darkness

Tuesday, 15 March 2022

Moderna plans three more mRNA vaccines, not all for infection

[SOTT]: Moderna produces one of three COVID shots available in the U.S. In November 2021, Moderna released data on third-quarter sales showing phenomenal profits from the vaccine of $5 billion worldwide and forecasted $18 billion for the year just from the mRNA vaccine. To take advantage of this revenue stream, the company announced they are developing three new mRNA vaccines for shingles, cancer and herpes.

At the start of the vaccine race, the Health and Human Services Operation Warp Speed pledged to deliver 300 million doses of the vaccine by 2021. This was just months after the pandemic had been declared in early 2020. Yet, developing a safe and effective vaccine normally takes years and begins with animal studies.

In addition to the speed at which the vaccine was developed, the shot did not fit the definition of a vaccine at that time, as the mRNA product the pharmaceutical companies were planning does not induce immunity in and of itself; rather, it delivers instructions to the recipient's cells to do that by producing their own proteins to fight the targeted disease. So what did the CDC do? They changed the definition of vaccine....<<<Read More>>>...